afyxtx.com Open in urlscan Pro
162.159.134.42  Public Scan

Submitted URL: https://www.inphena.com.linux36.curanetserver.dk/
Effective URL: https://afyxtx.com/
Submission: On June 22 via api from US — Scanned from DK

Form analysis 1 forms found in the DOM

GET https://afyxtx.com/

<form role="search" method="get" class="et-search-form" action="https://afyxtx.com/">
  <input type="search" class="et-search-field" placeholder="Search …" value="" name="s" title="Search for:">
</form>

Text Content

 * Research & Development
 * About Us
 * Management
 * News
 * Careers
 * Contact


Select Page
 * Research & Development
 * About Us
 * Management
 * News
 * Careers
 * Contact




WE IMPROVE PEOPLE’S LIVES
BY TRANSFORMING TOMORROW’S TREATMENTS


Get in touch


GLOBAL IMPACT

Our Research & Development, as well as reformulation of pharmaceuticals based on
our patented technologies, helps to improve challenging health issues.

We believe our focus will change people’s lives.

We research and develop inside obstetrics, oncology, as well as pain and
addiction.

Devasting conditions dramatically limit and impact peoples’ lives. We focus on
creating genuinely innovative medicines by pushing the boundaries of science.

 

\


NICHE PRODUCTS

AFYX is an innovative niche developer of pharmaceuticals aiming at securing
better treatments of diseases with unmet medical needs, such as cancer, women’s
health and high-scale pain.





INVESTOR RELATIONS

We aim at delivering our investors with continuous updates and information on
the development of AFYX. Our latest investor presentation is always available
here. Annual reports, financial information and other news from AFYX. Get in
touch.


TRUST INTEGRATED

AFYX is a specialty pharmaceutical/biopharmaceutical company established in 2024
through a merger of Lionheart ApS, Inphena ApS and AFYX Therapeutics A/S.

Dr. Claus J. Møller-San Pedro is the company CEO. Dr. Møller co-founded and
secured successful IPOs of 3 companies in the BioPharma Industry: OXiGENE Inc.
(OTLC); Genmab A/S (GMAB) and Y-mAbs Therapeutics, Inc.(YMAB).




INNOVATION

We are encouraging creativity and new ideas to drive progress and ensuring
openness and clarity in communications and actions.




INTEGRITY

We build trust through responsible actions and honest relationships. We achieve
when we collaborate and all work together.




RESPECT

We are going beyond simply being polite. Respect means treating all employees,
clients, vendors and stakeholders with dignity and worth.

HEADQUARTER

Agern Alle 24
DK-2970 Hørsholm
Denmark

CONTACT US

+45 7174 7174
info@afyxtx.com

ESSENTIALS

Mission & Values
Research & Development
Investor Relations